Hoyer D, Karpf A
Preclinical Research, Sandoz Ltd., Basel, Switzerland.
Eur J Pharmacol. 1988 May 20;150(1-2):181-4. doi: 10.1016/0014-2999(88)90766-2.
[125I]SCH 23982, a ligand reported to be very selective for dopamine D-1 receptors, binds with high affinity to membranes of pig choroid plexus (KD = 186 pM, Bmax = 142 fmol/mg protein). Saturation and competition experiments suggested that [125I]SCH 23982 labels a homogeneous population of sites. The rank order for affinity of agonists, 5-HT greater than or equal to DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane) much greater than dopamine greater than fenoldopam, and antagonists, metergoline greater than mesulergine = mianserin greater than SCH 23390 greater than methiothepin greater than ketanserin greater than fluphenazine much greater than (-)-sulpiride greater than (+)-sulpiride, was compatible with labelling of 5-HT1C receptors by [125I]SCH 23982. It also correlates very significantly with [3H]mesulergine binding to pig choroid plexus membranes. The effects of SCH 23390 and its analogues should not be systematically attributed to an interaction with D-1 receptors.
[125I]SCH 23982是一种据报道对多巴胺D-1受体具有高度选择性的配体,它能以高亲和力与猪脉络丛膜结合(解离常数KD = 186皮摩尔,最大结合量Bmax = 142飞摩尔/毫克蛋白质)。饱和及竞争实验表明,[125I]SCH 23982标记的是一类同质的位点。激动剂的亲和力排序为:5-羟色胺≥DOI(1-(2,5-二甲氧基-4-碘苯基)-2-氨基丙烷)>>多巴胺>非诺多泮;拮抗剂的亲和力排序为:麦角苄酯>美舒麦角=米安色林>SCH 23390>甲硫噻嗪>酮色林>氟奋乃静>>(-)-舒必利>(+)-舒必利,这与[125I]SCH 23982标记5-HT1C受体的情况相符。它与[3H]美舒麦角结合到猪脉络丛膜上的情况也具有非常显著的相关性。SCH 23390及其类似物的作用不应一概归因于与D-1受体的相互作用。